{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:19:19Z","timestamp":1786119559751,"version":"build-2736575974"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.1097\/01.npr.0000383661.45156.09","type":"journal-article","created":{"date-parts":[[2010,6,15]],"date-time":"2010-06-15T07:25:23Z","timestamp":1276586723000},"page":"44-50","source":"Crossref","is-referenced-by-count":3,"title":["Lyme disease"],"prefix":"10.1097","volume":"35","author":[{"given":"Virginia","family":"Savely","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"4","key":"R1-12-20210130","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1586\/14787210.2.4.533","article-title":"Treatment of Lyme disease: a medicolegal assessment.","volume":"2","author":"Johnson","year":"2004","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"2","key":"R2-12-20210130","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1586\/14787210.3.2.155","article-title":"Lyme disease: point\/counterpoint.","volume":"3","author":"Stricker","year":"2005","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"1","key":"R3-12-20210130","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1046\/j.1365-3024.2003.00605.x","article-title":"Ixodes ricinus tick salivary gland extract inhibits IL-10 secretion and CD69 expression by mitogen-stimulated murine splenocytes and induces hyporesponsiveness in B lymphocytes.","volume":"25","author":"Hannier","year":"2003","journal-title":"Parasite Immunol"},{"issue":"1","key":"R4-12-20210130","first-page":"72","article-title":"Lyme disease without erythema migrans: cause for concern Am J Med.","volume":"115","author":"Stricker","year":"2003","journal-title":""},{"issue":"4","key":"R5-12-20210130","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1001\/archinte.1990.00390160039009","article-title":"Serologic tests for Lyme disease: Interlaboratory variability.","volume":"150","author":"Luger","year":"1990","journal-title":"Arch Intern Med"},{"issue":"12","key":"R6-12-20210130","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1111\/j.1699-0463.1998.tb00269.x","article-title":"A rapid method for generating cystic forms of Borrelia burgdorferi, and their reversal to mobile spirochetes.","volume":"106","author":"Brorson","year":"1998","journal-title":"APMIS"},{"issue":"6","key":"R7-12-20210130","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1111\/j.1699-0463.1999.tb01594.x","article-title":"An in vitro study of the susceptibility of mobile and cystic forms of Borrelia burgdorferi to metronidazole.","volume":"107","author":"Brorson","year":"1999","journal-title":"APMIS"},{"key":"R8-12-20210130","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/1471-2334-9-79","article-title":"Diagnostic challenges of early Lyme disease: lessons from a community case series.","volume":"9","author":"Aucott","year":"2009","journal-title":"BMC Infect Dis"},{"issue":"5","key":"R9-12-20210130","first-page":"439","article-title":"Diagnostics of Lyme disease.","volume":"58","author":"Gasiorowski","year":"2007","journal-title":"Med Pr"},{"issue":"3","key":"R10-12-20210130","first-page":"438","article-title":"Chronic Lyme borreliosis at the root of multiple sclerosis--is a cure with antibiotics attainable Med Hypotheses.","volume":"64","author":"Fritzsche","year":"2005","journal-title":""},{"issue":"6","key":"R11-12-20210130","first-page":"195","article-title":"Borrelia infection and systemic lupus erythematosus.","volume":"17","author":"Federlin","year":"1989","journal-title":"Immun Infekt"},{"issue":"2","key":"R12-12-20210130","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1600-0404.2006.00727.x","article-title":"Motor neuron disease recovery associated with IV ceftriaxone and anti-Babesia therapy.","volume":"115","author":"Harvey","year":"2007","journal-title":"Acta Neurol Scand"},{"issue":"4","key":"R14-12-20210130","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1007\/s00284-005-0454-7","article-title":"Lyme disease associated with Alzheimers disease.","volume":"52","author":"Meer-Scherrer","year":"2006","journal-title":"Curr Microbiol"},{"issue":"6","key":"R15-12-20210130","doi-asserted-by":"crossref","first-page":"639","DOI":"10.3233\/JAD-2004-6608","article-title":"Borrelia burgdorferi persists in the brain in chronic lyme neuroborreliosis and may be associated with Alzheimer disease.","volume":"6","author":"Miklossy","year":"2004","journal-title":"J Alzheimers Dis"},{"issue":"5","key":"R16-12-20210130","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.mehy.2007.09.006","article-title":"The association between tick-borne infections, Lyme borreliosis and autism spectrum disorders.","volume":"70","author":"Bransfield","year":"2008","journal-title":"Med Hypotheses"},{"key":"R17-12-20210130","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1159\/000213070","article-title":"Clinical manifestations and diagnosis of Lyme borreliosis.","volume":"37","author":"Strle","year":"2009","journal-title":"Curr Probl Dermatol"},{"issue":"13-14","key":"R18-12-20210130","first-page":"601","article-title":"Limitation of serological testing for Lyme borreliosis: evaluation of ELISA and western blot in comparison with PCR and culture methods.","volume":"114","author":"Tylewska-Wierzbanowska","year":"2002","journal-title":"Wein Klin Wochenschr"},{"issue":"11","key":"R19-12-20210130","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1212\/WNL.45.11.2010","article-title":"Detection of Borrelia burgdorferi-specific antigen in antibody-negative cerebrospinal fluid in neurologic Lyme disease.","volume":"45","author":"Coyle","year":"1995","journal-title":"Neurology"},{"issue":"2","key":"R20-12-20210130","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1128\/JCM.30.2.370-376.1992","article-title":"Serodiagnosis of Lyme borreliosis by Western immunoblot: reactivity of various significant antibodies against Borrelia burgdorferi.","volume":"30","author":"Ma","year":"1992","journal-title":"J Clin Microbiol"},{"issue":"6","key":"R21-12-20210130","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1128\/JCM.34.6.1353-1354.1996","article-title":"Recommendation to include OspA and OspB in the new immunoblotting criteria for serodiagnosis of Lyme disease.","volume":"34","author":"Hilton","year":"1996","journal-title":"J Clin Microbiol"},{"issue":"3","key":"R22-12-20210130","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1128\/CMR.18.3.484-509.2005","article-title":"Diagnosis of Lyme borreliosis.","volume":"18","author":"Aguero-Rosenfeld","year":"2005","journal-title":"Clin Microbiol Rev"},{"issue":"1","key":"R24-12-20210130","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0165-2478(00)00316-3","article-title":"Decreased CD57 lymphocyte subset in patients with chronic Lyme disease.","volume":"76","author":"Stricker","year":"2001","journal-title":"Immunol Lett"},{"issue":"1","key":"R25-12-20210130","first-page":"111","article-title":"Longterm decrease in the CD57 lymphocyte subset in a patient with chronic Lyme disease.","volume":"9","author":"Stricker","year":"2002","journal-title":"Ann Agric Environ Med"},{"issue":"1","key":"R26-12-20210130","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1365-3083.2008.02191.x","article-title":"Complement split products c3a and c4a in chronic Lyme disease.","volume":"69","author":"Stricker","year":"2009","journal-title":"Scand J Immunol"},{"issue":"3","key":"R27-12-20210130","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1159\/000116362","article-title":"Complement split products C3a and C4a are early markers of acute Lyme disease in tick bite patients in the United States.","volume":"146","author":"Shoemaker","year":"2008","journal-title":"Int Arch Allergy Immunol"}],"container-title":["The Nurse Practitioner"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00006205-201007000-00012","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:31:38Z","timestamp":1786041098000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006205-201007000-00012"}},"subtitle":["A diagnostic dilemma"],"short-title":[],"issued":{"date-parts":[[2010,7]]},"references-count":25,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/01.npr.0000383661.45156.09","relation":{},"ISSN":["0361-1817"],"issn-type":[{"value":"0361-1817","type":"print"}],"subject":[],"published":{"date-parts":[[2010,7]]}}}